HER2 positive breast cancer - Globe Thesis

Keyword [HER2 positive breast cancer] Result: 61 - 78 \| Page: 4 of 4
61.	Induction Of EnR Stress By Melatonin Enhances The Cytotoxic Effect Of Lapatinib In HER2-positive Breast Cancer
62.	Research On The Activity Of ScFv Against HER2-positive Breast Cancer Enhanced By LP-scFv And Rapid Detection Of SARS-CoV-2
63.	Efficacy And Safety Of Neoadjuvant Pyrotinib For HER2-positive Breast Cancer And Predictive Value Of PIK3CA Mutations For Efficacy
64.	Influencing Factors And Predictors Of Effect Of Pathological Complete Response Of HER2-positive Breast Cancer Treated With Neoadjuvant Treatment And Mechanism Of Drug Resistance
65.	Mechanisms Underlying The Role Of RSK2 In Promoting The Proliferation And Migration In HER2 Positive Breast Cancer Cells
66.	Risk Factors Analysis And Prediction Model For Brain Metastasis Of HER2 Positive Breast Cancer
67.	A Study Of The Effectiveness And Its Mechanism Of Shenling Baizhu Power In Treating Pyrotinib-induced Diarrhea In HER2-positive Breast Cancer
68.	Efficacy And Safety Of T-DM1 In The Treatment Of HER2 Positive Breast Cancer: A Systematic Review And Meta-analysis
69.	The Inhibitory Effect And Mechanism Of Huaier Aqueous Extract On HER2 Positive Breast Cancer Cell SKBR3 With Overexpressed MYCN
70.	Clinical Significance And Basic Research Of PIK3CA Mutations In HER2 Positive Breast Cancer
71.	Enhancing ADCC Effect To Improve The Efficacy Of Trastuzumab In The Treatment Of HER2 Positive Breast Cancer
72.	The Mechanisms And Roles Of Abnormally Activated IGF2/IGF-1R/IRS1 Signaling In Herceptin Resistance Of Breast Cancer
73.	Efficacy Of Zercepac^? Compared With Herceptin^? Combined With Pertuzumab In Neoadjuvant Therapy For HER2 Positive Breast Cancer
74.	Construction And Validation Of A Predictive Model Of Pathological Complete Response Combined With MRI And Tumor Indicators For HER2-positive Breast Cancer After Neoadjuvant Targeted Therapy
75.	Using TCGA Database To Establish A Risk Prediction Model Of Drug Resistance In HER2 Positive Breast Cancer Patients After Targeted Therapy Based On Ferroptosis
76.	Efficacy Analysis Of Trastuzumab Combined With Pertuzumab In The Third-Line Treatment Of HER2-Positive Breast Cancer And The Value Of SOX11 In Predicting Its Efficacy
77.	Herceptin Functionalized SK-BR-3 Cell Membrane Wrapped Paclitaxel Nanocrystals For Enhancing The Targeted Therapy Effect Of HER2-positive Breast Cancer
78.	Comparison Of Neoadjuvant Trastuzumab Combined With Pyrotinib/pertuzumab In The Treatment Of HER2 Positive Breast Cancer
<<First <Prev Next> Last>> Jump to